This is a Validated Antibody Database (VAD) review about human XPG, based on 6 published articles (read how Labome selects the articles), using XPG antibody in all methods. It is aimed to help Labome visitors find the most suited XPG antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
XPG synonym: COFS3; ERCC5-201; ERCM2; UVDR; XPG; XPGC; DNA repair protein complementing XP-G cells; DNA excision repair protein ERCC-5; XPG-complementing protein; excision repair cross-complementation group 5; excision repair cross-complementing rodent repair deficiency, complementation group 5; xeroderma pigmentosum, complementation group G
Bethyl
rabbit polyclonal |
| Bethyl XPG antibody (Bethyl, A301-484A) was used in immunocytochemistry on human samples (fig 4e). Nucleic Acids Res (2018) ncbi |
rabbit polyclonal |
| Bethyl XPG antibody (Bethyl, A301-484A) was used in western blot on human samples (fig 3). Mol Cell Biol (2015) ncbi |
rabbit polyclonal |
| Bethyl XPG antibody (Bethyl Laboratories, A301-484A) was used in western blot on human samples at 1:3000 (fig 1). Cell Cycle (2015) ncbi |
Proteintech Group
rabbit polyclonal |
| Proteintech Group XPG antibody (ProteinTech, 11331-1-AP) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi |
Invitrogen
mouse monoclonal (8H7) |
| In order to elucidate ubiquitylation of XPC, Invitrogen XPG antibody (Thermo Scientific, 8H7) was used in immunocytochemistry on mouse samples at 1:400 (fig 2b). Nat Commun (2015) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (8H7) |
| Santa Cruz Biotechnology XPG antibody (Santa Cruz Biotechnology, sc-13563) was used in immunocytochemistry on human samples at 1:25. Genes Cells (2015) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments